Stock listing
NASDAQ:DNLI Denali Therapeutics Inc. Stock
Home listing (NASDAQ) of Denali Therapeutics Inc.
Follow Denali Therapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:DNLI
$18.74 USD -0.15 (-0.8%)
Close on Nov 13, 2026
- Day range
- $18.34 – $18.91 USDNov 13, 2026
- Volume
- 795,669 sharesNov 13, 2026
- Market cap
- $3.00B USDAt the close on Nov 13, 2026 · price × 159.8M shares outstanding
- 52-week range
- $15.34 – $27.30 USDLowest and highest trades, Nov 14, 2025 – Nov 13, 2026
- Traded on an average day
- $32.80M USDMedian day 1.43M shares · last 3 months, Aug 13, 2026 – Nov 13, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:DNLI · Home | $18.74 USD | -0.15 (-0.8%) | 795,669 | $18.77 | $18.91 | $18.34 | $18.89 | Close on Nov 13, 2026 |
| Frankfurt:4DN | €16.89 EUR | -0.605 (-3.5%) | — | €16.89 | €16.89 | €16.89 | €17.49 | Close on Nov 13, 2026 |
Daily closes
Last 3 months, Aug 13, 2026 – Nov 13, 2026 · NASDAQ:DNLI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $18.74 | -0.15 | -0.8% | $18.77 | $18.91 | $18.34 | 795,669 | |
| $18.89 | -0.84 | -4.3% | $19.39 | $19.60 | $18.80 | 1,309,618 | |
| $19.73 | -0.12 | -0.6% | $19.88 | $20.24 | $19.63 | 873,556 | |
| $19.85 | -0.48 | -2.4% | $20.01 | $20.69 | $19.72 | 975,842 | |
| $20.33 | +0.26 | +1.3% | $20.38 | $20.56 | $19.76 | 1,384,061 | |
| $20.07 | +0.35 | +1.8% | $19.97 | $20.36 | $19.78 | 1,586,646 | |
| $19.72 | -1.24 | -5.9% | $20.96 | $20.97 | $19.65 | 2,249,360 | |
| $20.96 | +1.51 | +7.8% | $21.23 | $22.19 | $19.75 | 4,648,983 | |
| $19.45 | +0.59 | +3.1% | $19.21 | $19.52 | $18.98 | 2,425,500 | |
| $18.86 | -0.08 | -0.4% | $19.11 | $19.20 | $18.32 | 1,234,803 | |
| $18.94 | -0.38 | -2.0% | $19.25 | $19.63 | $18.64 | 1,306,306 | |
| $19.32 | +0.03 | +0.2% | $19.35 | $19.78 | $19.14 | 1,442,610 | |
| $19.29 | +0.07 | +0.4% | $18.92 | $19.29 | $18.84 | 1,576,533 | |
| $19.22 | +0.56 | +3.0% | $18.48 | $19.32 | $18.40 | 1,482,028 | |
| $18.66 | +0.25 | +1.4% | $18.41 | $18.67 | $18.35 | 679,457 | |
| $18.41 | -0.25 | -1.3% | $18.49 | $18.50 | $18.01 | 1,005,558 | |
| $18.66 | -0.02 | -0.1% | $18.53 | $18.94 | $18.44 | 816,745 | |
| $18.68 | -0.25 | -1.3% | $18.93 | $19.13 | $18.58 | 1,429,264 | |
| $18.93 | +0.89 | +4.9% | $18.10 | $19.35 | $17.95 | 1,824,103 | |
| $18.04 | +0.43 | +2.4% | $17.61 | $18.36 | $17.33 | 2,688,860 | |
| $17.61 | -0.73 | -4.0% | $18.37 | $18.37 | $17.37 | 2,304,300 | |
| $18.34 | +0.47 | +2.6% | $18.04 | $18.53 | $18.01 | 1,566,200 | |
| $17.87 | -0.53 | -2.9% | $18.30 | $18.36 | $17.53 | 2,703,300 | |
| $18.40 | -0.55 | -2.9% | $18.82 | $19.20 | $18.15 | 1,939,100 | |
| $18.95 | -0.50 | -2.6% | $19.33 | $19.62 | $18.90 | 1,231,400 | |
| $19.45 | +0.78 | +4.2% | $18.46 | $19.53 | $18.46 | 1,341,000 | |
| $18.67 | -0.49 | -2.6% | $19.00 | $19.04 | $18.30 | 2,366,500 | |
| $19.16 | -0.12 | -0.6% | $18.95 | $19.43 | $18.89 | 1,314,500 | |
| $19.28 | -0.63 | -3.2% | $19.93 | $19.97 | $19.03 | 3,674,400 | |
| $19.91 | -0.09 | -0.4% | $20.09 | $20.09 | $19.54 | 1,717,700 | |
| $20.00 | -0.53 | -2.6% | $20.85 | $20.85 | $19.93 | 1,629,500 | |
| $20.53 | -0.14 | -0.7% | $20.55 | $20.85 | $20.40 | 1,939,700 | |
| $20.67 | -0.14 | -0.7% | $20.95 | $21.09 | $20.51 | 2,255,600 | |
| $20.81 | -0.17 | -0.8% | $20.88 | $21.01 | $20.41 | 1,390,300 | |
| $20.98 | +0.59 | +2.9% | $20.05 | $21.26 | $19.93 | 2,559,500 | |
| $20.39 | -0.08 | -0.4% | $20.46 | $20.60 | $19.96 | 1,257,500 | |
| $20.47 | +0.01 | 0.0% | $20.40 | $20.64 | $19.73 | 2,273,000 | |
| $20.46 | -1.14 | -5.3% | $21.50 | $21.51 | $20.33 | 1,914,000 | |
| $21.60 | +1.13 | +5.5% | $20.76 | $21.79 | $20.47 | 2,336,600 | |
| $20.47 | +0.75 | +3.8% | $19.99 | $20.55 | $19.40 | 2,393,800 | |
| $19.72 | -0.41 | -2.0% | $20.07 | $20.16 | $19.56 | 2,956,000 | |
| $20.13 | +0.07 | +0.3% | $20.57 | $20.65 | $19.90 | 1,421,400 | |
| $20.06 | -0.32 | -1.6% | $20.40 | $20.51 | $19.87 | 1,855,600 | |
| $20.38 | -0.84 | -4.0% | $21.01 | $21.10 | $20.27 | 1,837,300 | |
| $21.22 | +0.13 | +0.6% | $21.09 | $21.58 | $20.96 | 1,074,000 | |
| $21.09 | -0.31 | -1.4% | $21.65 | $21.79 | $21.06 | 1,239,500 | |
| $21.40 | -0.17 | -0.8% | $21.24 | $21.58 | $21.09 | 938,600 | |
| $21.57 | -0.51 | -2.3% | $21.69 | $22.06 | $21.34 | 2,091,500 | |
| $22.08 | -0.20 | -0.9% | $21.79 | $22.25 | $21.66 | 1,653,800 | |
| $22.28 | -0.52 | -2.3% | $22.32 | $22.48 | $22.15 | 799,600 | |
| $22.80 | -0.05 | -0.2% | $23.00 | $23.03 | $22.35 | 1,728,000 | |
| $22.85 | -0.415 | -1.8% | $23.33 | $23.86 | $22.53 | 1,768,600 | |
| $23.27 | -0.495 | -2.1% | $23.44 | $23.75 | $23.06 | 1,431,700 | |
| $23.76 | -0.24 | -1.0% | $23.72 | $24.01 | $23.41 | 985,800 | |
| $24.00 | -0.67 | -2.7% | $24.42 | $24.62 | $23.92 | 807,600 | |
| $24.67 | +0.10 | +0.4% | $24.43 | $24.74 | $24.16 | 700,100 | |
| $24.57 | -0.36 | -1.4% | $24.75 | $24.89 | $24.33 | 771,300 | |
| $24.93 | +0.73 | +3.0% | $24.86 | $25.26 | $24.81 | 1,120,500 | |
| $24.20 | -0.72 | -2.9% | $24.88 | $25.27 | $23.41 | 1,321,100 | |
| $24.92 | -0.03 | -0.1% | $25.25 | $25.37 | $24.60 | 681,000 | |
| $24.95 | -0.74 | -2.9% | $25.15 | $25.60 | $24.65 | 976,600 | |
| $25.69 | +1.38 | +5.7% | $25.00 | $25.70 | $24.61 | 1,150,300 | |
| $24.31 | -0.04 | -0.2% | $24.17 | $24.49 | $24.01 | 1,099,600 | |
| $24.35 | -0.05 | -0.2% | $24.29 | $24.66 | $24.11 | 1,003,100 | |
| $24.40 | -0.42 | -1.7% | $24.53 | $24.62 | $24.12 | 890,000 | |
| $24.82 | -0.45 | -1.8% | $25.24 | $25.64 | $24.81 | 1,346,800 |
- Ticker
- NASDAQ:DNLI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 3, 2026
Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
Latest earnings call · Nov 3, 2026
Denali Therapeutics (NASDAQ:DNLI) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 3, 2026
Q3 2026 Earnings Presentation
Earnings · 26 slides
Calls
Replays
Denali Therapeutics (NASDAQ:DNLI) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 4:30 PM ET
Watch TranscriptDenali Therapeutics (NASDAQ:DNLI) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
Nov 3, 2026
Closed $20.96 (+7.8%) on Nov 4, 2026
Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
Oct 30, 2026
Closed $18.94 (-2.0%) on Oct 30, 2026
Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026
Oct 22, 2026
Closed $18.41 (-1.3%) on Oct 23, 2026
Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
Aug 6, 2026
Closed $24.83 (+0.4%) on Aug 7, 2026
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
Jul 27, 2026
Closed $24.05 (+2.0%) on Jul 28, 2026
Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Barrier
Jul 9, 2026
Closed $25.68 (-5.6%) on Jul 10, 2026
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
Jun 18, 2026
Closed $23.31 (-0.8%) on Jun 18, 2026
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 21, 2026
Closed $19.30 (+2.5%) on May 21, 2026
Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights
May 7, 2026
Closed $19.62 (-0.5%) on May 8, 2026
Orsini Selected as the Exclusive Specialty Pharmacy and Home Infusion Partner for Denali Therapeutics' AVLAYAH™ (tividenofusp alfa-eknm)
Apr 20, 2026
Closed $20.54 (-0.1%) on Apr 20, 2026
Financings
Public offering of common stock and pre-funded warrants
Dec 10, 2025
Update: about US$200M · US$17.5 a share · Goldman Sachs & Co. LLC +5
Dealers: Goldman Sachs & Co. LLC (co-lead), J.P. Morgan Securities LLC (co-lead), Morgan Stanley & Co. LLC (co-lead), Jefferies LLC (co-lead), H.C. Wainwright & Co., LLC, B. Riley Securities, Inc.
Synthetic royalty on future net sales of tividenofusp alfa
Dec 4, 2025
Announced: US$275M
Buyers: Royalty Pharma plc (Initial payment of $200 million at closing and $75 million upon EMA approval, in exchange for a 9.25% royalty on worldwide net sales of tividenofusp alfa)
Use of proceeds: To advance development programs and prepare for the launch of tividenofusp alfa
Decks
Q3 2026 Earnings Presentation
Earnings · 26 slides · Nov 3, 2026
Q2 2026 Earnings Presentation
Earnings · 34 slides · Aug 6, 2026
Technical Presentation (February 2026)
Technical · 12 slides · February 2026
Technical Presentation (February 2026)
Technical · 15 slides · February 2026
Denali Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 122 in all · newest Nov 3, 2026 · oldest 2019
- Calls
- 2 calls with a replay · 2 with a transcript · latest Nov 3, 2026
- Decks
- 12 decks · latest Nov 3, 2026
Where Denali Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:DNLI · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A2H9G8 | LS Exchange | Germany | EUR |
| gettex:4DN | gettex | Germany | EUR |
| BX Swiss:DNLI | BX Swiss | Switzerland | CHF |
| Lang & Schwarz:A2H9G8 | Lang & Schwarz | Germany | EUR |
| B3:D2NL34 | B3 | Brazil | BRL |
| Frankfurt:4DN | Frankfurt | Germany | EUR |
| BOATS:DNLI | BOATS | United States | USD |
| Dusseldorf:4DN | Dusseldorf | Germany | EUR |
| Munich:4DN | Munich | Germany | EUR |
| Stuttgart:4DN | Stuttgart | Germany | EUR |
| Tradegate:4DN | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Denali Therapeutics Inc.